Patient Testimonial

Frank O.

Age: 69

Diagnosis: Primary Lateral Sclerosis

Treatment Date: June 2008 (2nd treatment)

Type of Treatment: Lumbar Puncture

Dear Dr. Casey Nabavi:

Over the last year Frank has made remarkable gains in nearly all areas measured. However, he has yet to see any gains in ankle movement. Most notable progress continued for up to 6 months after receiving his stem cell treatment in January. Since the 6th month mark he has been able to maintain in the majority of gains. Even though many areas saw a plateau at 6 months, his gross lower extremity strength and functional mobility have continued to improve. As noted by the measurement grid, he is now able to ambulate for 300 feet using a straight cane. His functional mobility continues to be limited by low back pain but trunk stability has also shown improvement over the year, which has helped with increased ambulation.

It has been exciting to watch Frank’s progress over the years. Despite continual therapy there was a documented decline over the last few years. Now I see a man reclaiming his independence through function gained by your stem cell therapy.

Cellulogix International

Cellulogix Biosciences is the parent of a network of companies in the field of biotechnology.

Cellulogix International falls under this parent company and was designed for the purpose of providing umbilical cord and adult stem cell treatments to patients all over the globe.

Cellulogix International currently has clinics in North and Central America (near the California border in Zona Rio, Mexico and also in Guatemala City, Guatemala) There is another clinic for European patients located in Istanbul, Turkey. On the horizon are clinics in Moscow, Russia and Berlin, Germany.

Cellulogix

Cellulogix International was designed for the purpose of providing safe and ethical access to stem cell treatment using umbilical cord blood and adult stem cells. We are encouraged by the wonderful results we see to continue opening clinics and providing these treatments to patients all over the globe.

Apheresis

Cellulogix International is proud to announce the launch of the new adult stem cell treatment procedure referred to as “Apheresis” methodology.

This procedure involves the extraction of stem cells and Mononuclear cells from peripheral blood utilizing an Apheresis instrument. The cells are reconditioned on site and then injectioned back into the patient. This treatment has the potential to significantly help patients of various conditions. It is also used to reduce the signs and symptoms of aging.

Global Company

The month of December was a busy one for Dr. Casey Nabavi and his associates. Dr. Nabavi traveled to Europe and Asia to meet with contacts and engage them in new ventures. We look forward to growing the company to include centers in Central and South America as well as Europe, Asia and Africa. Dr. Nabavi's hope is to create a global network of medical professionals to assist patients all over the world. There are many advances on the horizon and Cellulogix International plans to make these technologies accessible to all.